277 related articles for article (PubMed ID: 21478701)
41. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
42. The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.
Castle PE; Gage JC; Wheeler CM; Schiffman M
Obstet Gynecol; 2011 Dec; 118(6):1222-1229. PubMed ID: 22105250
[TBL] [Abstract][Full Text] [Related]
43. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
Dane C; Batmaz G; Dane B; Cetin A
Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus type 16 E6 gene variations in Chinese population.
Cai HB; Chen CC; Ding XH
Eur J Surg Oncol; 2010 Feb; 36(2):160-3. PubMed ID: 19699050
[TBL] [Abstract][Full Text] [Related]
45. Lower cost strategies for triage of human papillomavirus DNA-positive women.
Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
[TBL] [Abstract][Full Text] [Related]
46. Distribution of human papillomavirus type 16 E6 and E7 gene variants in the progression of cervical dysplasia in Korean women.
Lee CW; Bae JH; Lee SJ; Ho EM; Lee IH; Park YG; Park JS
J Obstet Gynaecol Res; 2011 Oct; 37(10):1320-6. PubMed ID: 21535311
[TBL] [Abstract][Full Text] [Related]
47. The role of mRNA E6/E7 HPV high oncogenic risk expression in colposcopy of cervical intraepithelial neoplasia (CIN).
Galarowicz B; Jach R; Kidzierska J; Dyduch G; Zajac K; Pityński K; Banaś T; Huras H; Streb J; Dulińska-Litewka J; Hosiawa V; Juszczak M; Milewicz T
Przegl Lek; 2012; 69(9):651-7. PubMed ID: 23401983
[TBL] [Abstract][Full Text] [Related]
48. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
49. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
J Clin Pathol; 2006 Jan; 59(1):40-7. PubMed ID: 16394279
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
[TBL] [Abstract][Full Text] [Related]
51. Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia.
Baba S; Taguchi A; Kawata A; Hara K; Eguchi S; Mori M; Adachi K; Mori S; Iwata T; Mitsuhashi A; Maeda D; Komatsu A; Nagamatsu T; Oda K; Kukimoto I; Osuga Y; Fujii T; Kawana K
Virol J; 2020 Mar; 17(1):32. PubMed ID: 32143682
[TBL] [Abstract][Full Text] [Related]
52. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
Cattani P; Zannoni GF; Ricci C; D'Onghia S; Trivellizzi IN; Di Franco A; Vellone VG; Durante M; Fadda G; Scambia G; Capelli G; De Vincenzo R
J Clin Microbiol; 2009 Dec; 47(12):3895-901. PubMed ID: 19828739
[TBL] [Abstract][Full Text] [Related]
53. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.
Andersson S; Hansson B; Norman I; Gaberi V; Mints M; Hjerpe A; Karlsen F; Johansson B
Int J Oncol; 2006 Sep; 29(3):705-11. PubMed ID: 16865288
[TBL] [Abstract][Full Text] [Related]
54. Molecular Variants of HPV Type 16 E6 Among Honduran Women.
Tabora N; Melchers WJ; van Doorn LJ; Quint W; Ferrera A
Int J Gynecol Cancer; 2010 Apr; 20(3):323-8. PubMed ID: 20375791
[TBL] [Abstract][Full Text] [Related]
55. Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women.
Zhao J; Zhu J; Guo J; Zhu T; Zhong J; Liu M; Ruan Y; Liao S; Li F
J Med Virol; 2020 Mar; 92(3):372-381. PubMed ID: 31670402
[TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
57. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
58. [Differentiation of an integrated and episomal HPV-16 DNA using real-time PCR in cervical specimens of women diagnosed with intraepithelial lesions and invasive cervical cancer].
Szostek S; Zawilińska B; Klimek M; Wójcik K; Koprynia M; Kosz-Vnenchak M
Ginekol Pol; 2011 Jun; 82(6):441-5. PubMed ID: 21853934
[TBL] [Abstract][Full Text] [Related]
59. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
[TBL] [Abstract][Full Text] [Related]
60. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]